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Experimental allergic encephalomyelitis (EAE) can 
be produced by injecting animals with either a homo- 
genate of whole cnetral nervous tissue or basis protein 
extracted from central nervous tissue myelin together 
with Freund’s complete adjuvant (FCA) [ 1,2] . Ex- 
perimental allergic neuritis (EAN) is induced by inject- 
ing homogenate of whole sciatic nerve with FCA 
[3-61. Because EAE and EAN have many similarities 
we thought that the antigen responsible for EAN might 
be a basic protein from peripheral nerves. 
Bovine sciatic nerve (30 g) was frozen in liquid 
nitrogen and ground to a powder. The powder was 
defatted with cold chloroform: methanol (2: 1, v/v), 
dried and extracted with 450 ml HCl(O.05 M) con- 
taining NaCl(0.2 M). The acid extract (pH 2.5-3) 
was adjusted to pH 5 and dialysed against distilled 
water at 5°C overnight. The extract was concentrated 
and mixed with CM-Sephadex (C-25,2 g). The non- 
adsorbed material (SNl) contained proteins of high 
molecular weight. The adsorbed fraction (SN2) was 
eluted with buffer (0.25 M NazHPO,, 1 M NaCl, 
pH 8.0) and contained basic proteins of low mole- 
cular weight. Fraction SN2 was chromatographed on 
Sephadex G-50 with 1M acetic acid as solvent and 
yielded three fractions (fig. 1). All fractions were 
freeze-dried and from the dry-weights it was estimated 
that 100 mg fresh sciatic nerve contained 3 1 c(g of 
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fraction SN2C. All fractions were examined by poly- 
acrylamide gel electrophoresis at pH 2.5 [7] (fig. 2). 
It can be seen that fraction SN2A, the high mole- 
cular weight fraction from chromatography on 
Sephadex G 50 (fig. 1) contains slow moving proteins. 
Fraction SN2B contains the major basic protein of 
fraction SN2, while fraction SN2C, the ‘ow mole- 
cular weight fraction from Sephadex chromatography 
contains a fast moving component contaminated with 
some of the major component. 
Using gel filtration with reference proteins (fig. l), 
fraction SN2C was found to have a molecular weight 
of approximately 10.000, which is slightly less than 
Fig. 1. Elution profile of fraction SN2 on Sephadex G-50 
column (2.5 cm X 138.5 cm). Elution was carried out at room 
temperature with 1M acetic acid. The peak of blue dextran 
appeared at 228 ml and that of cytochrome c at 257 ml un- 
der these conditions. 
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Amino acid composition and electrophoretic behaviour of 
basic proteins from bovine sciatic nerve (SN2C) and bovine 
spinal cord [ 21. 
SN2B SNZC 
Spinal cord 
Basic protein 
*Origin 
Amino acid composition (moles/100 moles) 
Fig. 2. Polyacrylamide gel electrophoresis of sciatic nerve 
fractions. Electrophoresis was carried out in 15% polyacry- 
lamide gel in formic acid:acetic acid:water (1:4:45, by vol.), 
4M urea, pH 2.5 for 2 hr at 900 V (1) Sciatic nerve acid ex- 
tract, (2) SNl, (3) SN2, (4) SN?A, (5) SN2B, (6) SN2C. 
that of the encephalitogenic basic protein from 
bovine spinal cord [2] . Amino acid analysis (table 1) 
showed marked differences between the compositions 
of the basic proteins of sciatic nerve and spinal cord. 
Recently peripheraP and central myelin have been 
shown to contain basic proteins of markedly different 
amino acid composition [8,9]. It is probable that frac- 
tion SN2C is derived from peripheral myelin. Electro- 
phoresis of central and peripheral nervous tissue basic 
protein in polyacrylamide gel was carried out at three 
different pH values. Mobilities relative to cytochrome 
c (IV, values) [7] are given in table 1. 
Asp 
Thr 
Ser 
Glu 
Pro 
Gly 
Ala 
Val 
; cys 
Met 
Ile 
Leu 
Tyr 
Phe 
LYS 
His 
Arg 
Trp 
8.4 
7.9 
1.3 
11.5 
0.7 
10.5 
1.5 
6.8 
1.3 
1.7 
4.0 
1.8 
1.5 
3.8 
14.0 
1.0 
5.9 
None 
9.9 6.9 
9.0 4.4 
1.6 9.8 
10.2 6.8 
1.5 1.4 
10.2 14.5 
5.9 8.4 
6.7 2.2 
0.3 0.0 
1.6 1.1 
4.3 1.8 
7.8 6.2 
1.5 2.4 
4.0 4.6 
13.1 1.9 
0.9 5.7 
5.5 9.5 
Present 0.6 
Electrophoretic behaviour 
PH hfc values* 
2.5 0.81 1.32 0.75 
4.6 0.70 0.71 0.45 
9.0 0.85 0.85 0.56 
* Mobility relative to cytochrome c [5]. 
Five groups of adult guinea pigs were used to test 
sciatic nerve fractions for ability to produce disease 
(table 2). Samples were injected into both hind foot 
pads. Each guinea pig received 0.1 ml of a mixture of 
0.05 ml of an aqueous solution of a sciatic nerve 
fraction (containing protein equivalent to 100 mg 
fresh sciatic nerve) and 0.05 ml FCA. 
nerve (SN) developed signs of neurological disease. 
Five had histological peripheral nerve lesions consist- 
ing of myelin degeneration and axis cylinder fragmen- 
tation; and of these, twoo with marked degeneration 
had associated infiltration of lymphocytes and poly- 
morphonuclear leucocytes (polymorphs). One animal 
had minimal central nervous system lesions consisting 
of margination of vessels by polymorphs. 
The animals were observed daily and killed when Animals injected with the mixture of basic protein 
disease was apparent or at 30 days. Brain, spinal cord (SN2) or the low molecular weight fraction (SN2C) 
and sciatic nerve were immediately fixed in formalin; developed incontinence and paralysis of the hind 
at least six sections from each tissue were stained with limbs, and on histological examination were found to 
haemotoxylin and eosin and examined. All six guinea have vascular lesions in the brain and spinal cord but 
pigs injected with the whole homogenate of sciatic no peripheral nerve lesions. The vascular lesions seen, 
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Table 2 
Results of injection of sciatic nerve fractions into guinea pigs. 
the reactive sera were CLZ,@Jl5,, 2 2.8 and 8 pg/ml for 
animal injected with SN2 arr8’0.3 for SN2C. 
Neurological Disease** 
Antigen No. * Clinical Histological 
CNS PNS 
P M P M 
SN I 6 1 0 5 2 
SN2 7 6 6 6 0 0 
SN2A 5 0 1 0 0 0 
SN2B 5 0 0 0 0 0 
SNZC 5 5 3 5 0 0 
* Number of animals injected. 
** Number of animals with symptoms. 
CNS = Brain and spinal cord; PNS = Sciatic nerve; P = Margina- 
tion of vessels with polymorphonuclear leukocytes and/or 
infiltration of tissue with polymorphonuclear leukocytes; 
M = Perivascular or diffuse infiltration of tissue with mono- 
nuclear leukocytes; SN = Whole sciate nerve; SN2 = Mixed 
basic proteins; SN2A, SNZB and SNZC = fractions from gel 
filtration of SN2, see fig. 1. 
consisted of migration of polymorphs through vessels 
into the perivascular brain substance, vascular endo- 
thelial proliferation and mononuclear cell infiltration 
into the vessel walls and perivascular brain substance, 
these being lesions usually seen in EAE. Animals in- 
jected with fractions SN2A and SN2B showed no 
disease, although one animal injected with SN2A 
showed mild histological lesions in the central ner- 
vous system. It appears that the protein responsible 
for the induction of the disease is the fast moving 
component of fraction SN2C. 
Antigenic cross-reactivity between the encephali- 
togenic basic proteins,of central nervous tissue and 
sciatic nerve was studied by competitive inhibition 
using radioimmunoassay [lo] . Samples were pre- 
pared containing a standard amount of anti-EP rabbit 
serum and 1251-EP (0.1 pg) diluted to 1 ml with a mix- 
ture of normal rabbit serum (1 part) and Tris-acetate 
buffer (0.2 M, pH 7.3,9 parts). Various amounts of 
unlabelled EP were added to these samples, the mix- 
tures let stand for 12 hr at 4°C and tested by radio- 
immunoassay. Similar series of tests were carried out 
using SN2C and lysozyme (a protein unrelated to EP 
but of similar charge and molecular size) instead of EP. 
The degree of inhibition of the binding between 
1251-EP and anti-EP serum was determined by plotting 
the amount of 1251-EP bound against the weight of 
added EP, SN2C and lysozyme. It was found that 
0.6 pg EP and 6 Erg SN2C caused 50% inhibition of the 
binding between 1251-EP and anti-EP serum, whilst 
no inhibition was caused by the addition of up to 
600 pg lysozyme. Thus, antigenic cross-reactivity was 
shown to exist between EP and SNZC. 
We have shown that the injection of a sholw homo- 
genate of sciatic nerve produced histological lesions 
in the sciatic nerves with only minimal changes in the 
spinal cord in one animal. Hall [6] found histological 
lesions confined to the peripheral nervous tissue when 
he injected guinea pigs with homogenised sciatic 
nerve with FCA. However, Waksman [ 1 l] reported 
histological changes in both the central and peripheral 
nervous tissue in about 50% of guinea pigs injected 
with sciatic nerve homogenates with FCA. 
The surprising finding that basic protein from Unlike the sciatic nerve homogenate, the basic 
peripheral nerve could induce a disease in the central protein isolated from sciatic nerve produced lesions 
nervous system rather than in the peripheral system only in central nervous tissue. It seems that during 
led us to examine the sera from the five experimental the fractionation the capacity to induce EAN was 
groups for antibody to encephalitogenic basic protein. lost. This unexpected and unusual result was sup- 
The technique of gel filtration radio-immunoassay ported by our finding that basic protein from sciatic 
with iodinated (1251) encephalitogenic protein from nerve shared antigenic determinants with a known 
central nervous tissue (1251-EP) as antigen was used encephalitogenic basic protein from central nervous 
[lo] . The sera taken at death from five guinea pigs tissue (EP) as shown by its capacity to induce anti- 
injected with fraction SN2 and one injected with body reactive with 1251-EP and to inhibit the binding 
fraction SN2C had antibodies which reacted with between 1251-EP and anti-EP serum when tested by 
1251-EP, whilst serum from animals in the other radio-immunoassay. It is now known that intact EP is 
groups did not. The antigen binding capacities, ex- not required for the induction of EAE. Polypeptides 
pressed as pg 1z51-EP bound/ml undiluted serum, for from this protein are highly encephahtogenic [ 12-I 41. 
11 
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It is possible that the protein from sciatic nerve 
shares a common encephalitogenic determinant with 
EP 
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